In Vivo Toxicology Market Worth $6.14 Billion | Increasing Research in Oncology and Personalized Medicine

In Vivo Toxicology Market

PUNE, India, 2020-Oct-07 — /EPR Network/ —

According to the new market research report “In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) – Global Forecast” published by MarketsandMarkets™.

Revenue Growth Opportunities and Growth Drivers?

The Global In Vivo Toxicology Market is expected to grow at a CAGR of 6.9% during the forecast period to reach to USD 6.14 Billion.

Growth Driver in Depth:

• Increasing Pharmaceutical R&D Activities
• Mandatory Government Regulations for Animal Testing
• Innovations in Animal Models
• Exclusive In Vivo Toxicology Tests
• Increasing Research in Oncology and Personalized Medicine
• Rising Demand for Humanized Animal Models

Browse 124 tables and 38 figures spread through 196 pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=105308811

The consumables segment is expected to hold the largest share of the market

Based on product, the in vivo toxicology market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models. The consumables segment is expected to account for the largest share of the market owing to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, increasing usage of reagents and kits for biological sample analysis.

By testing type, sub-acute toxicity testing to register the highest CAGR during the forecast period

The in vivo toxicology market is segmented by testing type into chronic, sub-chronic, sub-acute, and acute toxicology testing. The sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing focus on neurological and anti-viral drug research, which requires more than two weeks of toxicity studies.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105308811

The US is estimated to account for the largest share of the in vivo toxicology market, followed by Germany and the UK. However, China is expected to grow at the highest CAGR during the forecast period. Factors such as rising R&D funding and collaborations; initiatives by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of the market in China.

The major players in the global in vivo toxicology market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US).